Gut bacteria tested as potential new weapon against bowel disease
Disease control
Completed
This small, early-stage study tested the safety of a new treatment called MB310, which is made of specific live bacteria. It involved 29 adults with active, mild-to-moderate ulcerative colitis. The main goal was to see if the treatment was safe and if the bacteria could successfu…
Phase: PHASE1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC